Reduced secretion of neuronal growth regulator 1 contributes to impaired adipose-neuronal crosstalk in obesity.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
25 11 2022
Historique:
received: 30 06 2021
accepted: 09 11 2022
entrez: 26 11 2022
pubmed: 27 11 2022
medline: 30 11 2022
Statut: epublish

Résumé

While the endocrine function of white adipose tissue has been extensively explored, comparatively little is known about the secretory activity of less-investigated fat depots. Here, we use proteomics to compare the secretory profiles of male murine perivascular depots with those of canonical white and brown fat. Perivascular secretomes show enrichment for neuronal cell-adhesion molecules, reflecting a higher content of intra-parenchymal sympathetic projections compared to other adipose depots. The sympathetic innervation is reduced in the perivascular fat of obese (ob/ob) male mice, as well as in the epicardial fat of patients with obesity. Degeneration of sympathetic neurites is observed in presence of conditioned media of fat explants from ob/ob mice, that show reduced secretion of neuronal growth regulator 1. Supplementation of neuronal growth regulator 1 reverses this neurodegenerative effect, unveiling a neurotrophic role for this protein previously identified as a locus associated with human obesity. As sympathetic stimulation triggers energy-consuming processes in adipose tissue, an impaired adipose-neuronal crosstalk is likely to contribute to the disrupted metabolic homeostasis characterising obesity.

Identifiants

pubmed: 36433953
doi: 10.1038/s41467-022-34846-w
pii: 10.1038/s41467-022-34846-w
pmc: PMC9700863
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7269

Subventions

Organisme : British Heart Foundation
ID : RG/16/14/32397
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/F/21/110053
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Cell. 2015 Sep 24;163(1):84-94
pubmed: 26406372
Nat Genet. 2010 Nov;42(11):937-48
pubmed: 20935630
Nature. 2020 Jul;583(7818):839-844
pubmed: 32699414
J Transl Med. 2020 Feb 11;18(1):68
pubmed: 32046736
Diabetes. 2018 Aug;67(8):1549-1560
pubmed: 29794241
J Neurosci Methods. 2016 Jun 15;266:32-41
pubmed: 27031947
Nature. 2019 May;569(7755):229-235
pubmed: 31043739
Front Mol Neurosci. 2016 Jan 13;8:89
pubmed: 26793057
Nat Neurosci. 2008 Jun;11(6):649-58
pubmed: 18382462
Circ Res. 2009 Feb 27;104(4):541-9
pubmed: 19122178
Nat Commun. 2020 May 1;11(1):2132
pubmed: 32358539
Trends Pharmacol Sci. 2015 Jul;36(7):461-70
pubmed: 26022934
Vasc Health Risk Manag. 2013;9:105-16
pubmed: 23576873
Protein Cell. 2018 Jun;9(6):527-539
pubmed: 29589323
Brain. 2018 Sep 1;141(9):2772-2794
pubmed: 30059965
Cell Metab. 2018 Jan 9;27(1):226-236.e3
pubmed: 29320703
J Proteomics. 2011 Jun 10;74(7):1068-79
pubmed: 21439414
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2227-2243
pubmed: 32640901
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
J Biol Chem. 2015 Feb 13;290(7):4330-42
pubmed: 25538237
Anal Biochem. 2011 Aug 15;415(2):215-7
pubmed: 21565151
Nature. 1993 Dec 23-30;366(6457):740-2
pubmed: 8264795
Brain Res. 2008 Aug 11;1224:1-11
pubmed: 18602091
Cell Metab. 2017 Oct 3;26(4):686-692.e3
pubmed: 28918935
J Lipid Res. 2005 Nov;46(11):2347-55
pubmed: 16150820
Circulation. 2012 Aug 28;126(9):1067-78
pubmed: 22855570
Am J Physiol Regul Integr Comp Physiol. 2013 Apr 1;304(7):R543-52
pubmed: 23389108
Int J Obes (Lond). 2019 Sep;43(9):1769-1782
pubmed: 31086253
Nat Med. 2017 Nov;23(11):1309-1318
pubmed: 29035364
Nat Commun. 2018 Nov 26;9(1):4974
pubmed: 30478315
Bioinformatics. 2004 Dec 12;20(18):3705-6
pubmed: 15297296
J Gerontol A Biol Sci Med Sci. 2013 Jul;68(7):780-92
pubmed: 23213032
Nat Genet. 2009 Jan;41(1):25-34
pubmed: 19079261
Physiol Rev. 2004 Jan;84(1):277-359
pubmed: 14715917
Clin Exp Hypertens A. 1991;13(2):277-96
pubmed: 2065467
Nat Med. 2013 Oct;19(10):1252-63
pubmed: 24100998
Nat Rev Endocrinol. 2019 Sep;15(9):507-524
pubmed: 31296970
FASEB J. 2002 Jul;16(9):1057-63
pubmed: 12087067
Cell. 2016 Nov 3;167(4):973-984.e12
pubmed: 27814523
J Biol Chem. 2012 Jul 27;287(31):25927-40
pubmed: 22692213
Philos Trans A Math Phys Eng Sci. 2016 Apr 13;374(2065):20150202
pubmed: 26953178
Nat Biotechnol. 2019 Apr;37(4):420-423
pubmed: 30778233
Cell Metab. 2007 Nov;6(5):363-75
pubmed: 17983582
Nat Med. 2011 Feb;17(2):200-5
pubmed: 21258337
Biochem Biophys Res Commun. 2017 Jan 22;482(4):1367-1374
pubmed: 27940359
Europace. 2018 Jul 1;20(7):1201-1208
pubmed: 28582578
Trends Neurosci. 2017 May;40(5):295-308
pubmed: 28359630
Diabetes. 2010 Dec;59(12):3008-16
pubmed: 20841607
Science. 1995 Jul 28;269(5223):540-3
pubmed: 7624776
Matrix Biol. 2016 Jan;49:10-24
pubmed: 26163349
Circulation. 2018 Jul 3;138(1):67-79
pubmed: 29371216
Life Sci Alliance. 2019 Sep 30;2(5):
pubmed: 31570514
Nat Rev Endocrinol. 2017 Jan;13(1):26-35
pubmed: 27616452
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1458-64
pubmed: 19608970
Exp Mol Med. 2016 Mar 11;48:e215
pubmed: 26964831
Nat Genet. 2009 Jan;41(1):18-24
pubmed: 19079260
J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56
pubmed: 15181022
Mol Cell Proteomics. 2007 Apr;6(4):589-600
pubmed: 17255083

Auteurs

Elisa Duregotti (E)

King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.

Christina M Reumiller (CM)

King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.

Ursula Mayr (U)

King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.

Maria Hasman (M)

King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.

Lukas E Schmidt (LE)

King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.

Sean A Burnap (SA)

King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.

Konstantinos Theofilatos (K)

King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.

Javier Barallobre-Barreiro (J)

King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.

Arne Beran (A)

Institute of Translational Pharmacology, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Maria Grandoch (M)

Institute of Translational Pharmacology, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Alessandro Viviano (A)

Department of Cardiothoracic Surgery, St. George's Hospital, University of London, London, UK.
Department of Cardiothoracic Surgery, Hammersmith Hospital, Imperial College London, London, UK.

Marjan Jahangiri (M)

Department of Cardiothoracic Surgery, St. George's Hospital, University of London, London, UK.

Manuel Mayr (M)

King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK. manuel.mayr@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH